Eisaku Iwanaga, Tomoko Nanri, Naofumi Matsuno, Toshiro Kawakita, Hiroaki Mitsuya and Norio Asou (2009) “A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia”, Haematologica. Pavia, Italy, 94(3), pp. 433-435. doi: 10.3324/haematol.13283.